Dr. Keith Humphreys
๐ค SpeakerAppearances Over Time
Podcast Appearances
So all those processes is how gateways work.
The lie was that it was just cannabis.
And this actually fits with the general lie, I would say, is that alcohol is a drug and we pretend that it isn't.
So, you know, you mentioned like people getting drunk at science conferences or health conferences.
I have seen conferences, political events where people spend all day demonizing drug users and talking about, you know, the threat of drugs and how evil drugs are and how we have to destroy all drugs.
And then they all go to the bar and get drunk as if they are not drunk.
drug users not wanting to admit that alcohol is a drug is a very useful for the industry but it was also just useful politically because you know you could say well the big threat to kids is cannabis when you know it's much much more likely a kid was going to get in trouble with alcohol than with cannabis these days there's a lot of discussion about psychedelics broad category of drugs lsd psilocybin mdma is an empathogen not a psychedelic but somehow it's been lumped into it and methyl
Yeah, I mean, they're exciting, in part because we haven't really made much progress in pharmacotherapy in the last 20 years, you know, for lots of things, for depression, for addiction, you know, so the thought that these might work, and I think they're other than the GLP-1s, you know, one of the, you know, probably say the second, I'd say my second bet on that, I put my first one in GLP-1 agonist.
There is an awful lot of hype, but real things can be hyped.
You know, so the fact that there are a lot of extravagant claims being made and also, again, talking about industry, you know, there are people who are hoping to make a huge sum of money on these medications.
But there's also something there.
You know, you could look at different pilot studies, you know, small trials.
They are encouraging.
And I'm glad that, you know, it's a lot easier now to do these types of studies.
You know, we just had my friend Dr. Todd Korthis down to Stanford.
You know, he's from Oregon.
You know, Oregon is doing these things.
probably similar experience to what your friend had where you get, you know, you have preparation with a trained person, you get the medication and then you do the integration session afterwards and there are, again, people would say it's transformative for them.
There are also people who have very bad experiences on them too though, it has to be said and that's why
we don't just say, all right, let's just use this as our frontline.